Vera de Jonge
3 papers found
Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myelomaDownload from doi.org
Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatmentUpload
Missing publications? Search for publications with a matching author name.